Dr. Paola Arlotta's lab at Harvard University focuses on understanding how the brain develops, particularly in relation to neurodevelopmental disorders like autism. They use advanced techniques to create models of the human brain using organoids, which are miniature, simplified versions of the brain. By studying these organoids, the lab investigates how specific genetic mutations affect neuron development and brain circuits, aiming to uncover the underlying causes of autism spectrum disorder (ASD).

Dr. Kevin Cummings's lab studies how the brain processes and responds to critical conditions like hypoxia, which is low oxygen levels. His team examines how certain brain circuits can affect heart rate and blood pressure recovery in infants and adults, particularly related to areas affected by Sudden Infant Death Syndrome (SIDS) and sleep apnea. Through a combination of rodent studies and human tissue analyses, they aim to uncover new insights that might lead to better prevention strategies for these serious health issues.

Dr. John E. Downey's lab at the University of Chicago focuses on enhancing brain-computer interfaces to help individuals with paralysis use prosthetic arms more effectively in daily life. The team investigates how to improve the coordination of arm and hand movements and harness more brain activity for better decoding. By developing biomimetic decoders and testing them in realistic virtual scenarios, they aim to create more reliable and flexible assistive technologies for users.

Dr. Kevin L. Gardner's lab focuses on understanding breast cancer, particularly in women of African ancestry and those in the African diaspora, who face higher mortality rates from this disease. The lab investigates a protein called Kaiso, exploring its potential as a biomarker for predicting breast cancer outcomes and how it interacts with the tumor microenvironment. By combining advanced genetic analysis techniques, the research aims to develop better prognostic models and therapeutic strategies for breast cancer.

Dr. Wenjun Guo's lab at Albert Einstein College of Medicine focuses on understanding how certain breast cancer cells evade the immune system and progress into aggressive cancers. The lab studies basal-like breast cancer, which significantly affects younger women and those with specific genetic backgrounds. The aim is to identify new strategies to prevent this type of cancer by targeting early-stage stem-like cells that play a crucial role in cancer development.

Dr. Sheila A Stewart's lab at Washington University focuses on understanding how specific types of cells in the breast cancer environment, especially senescent cancer-associated fibroblasts (senCAFs), contribute to the progression of breast cancer. By studying the interactions between these cells and tumor cells, the lab seeks to uncover new strategies for improving cancer treatments. Their research aims to reveal how senCAFs alter the immune response and the physical properties of the tissue around tumors, potentially opening avenues for innovative therapies.

Dr. Jonathan R. Brestoff's lab at Washington University focuses on understanding how immune cells, especially neutrophils, regulate brown adipose tissue (BAT) function and thermogenesis, potentially influencing metabolic diseases like obesity and type 2 diabetes. Additionally, his research explores intercellular mitochondria transfer as a novel therapeutic approach for treating Leigh Syndrome, a serious mitochondrial disease. The lab aims to uncover mechanisms that could lead to new treatments for these conditions.

Dr. Shaun R. Brinsmade's lab at Georgetown University focuses on understanding how the bacteria Staphylococcus aureus interacts with other bacteria, particularly in polymicrobial infections like chronic wounds. His research investigates the role of branched-chain fatty acids—essential lipids for bacterial survival and virulence—highlighting how these fatty acids can be salvaged and synthesized in the presence of other bacteria. Ultimately, the goal is to develop new treatments for complex infections that are worsened by multiple bacterial species working together.

Dr. Janice L. Brissette's lab at SUNY Downstate Medical Center focuses on improving cancer treatment by developing a novel diagnostic biomarker to predict patient responses to specific breast cancer therapies. The lab investigates how changes in the protein p27Kip1 can indicate whether patients with metastatic breast cancer will benefit from CDK4/6 inhibitors, which are crucial for managing certain breast cancers. The research aims to make cancer treatments more effective and personalized.

Dr. Ali H. Brivanlou's lab focuses on using marmoset monkeys to study Huntington's disease, a complex neurodegenerative disorder that affects movement and cognition. The lab aims to create genetic models that mirror human conditions by employing advanced techniques like CRISPR and stem cell technologies. By understanding the molecular basis of Huntington's disease in a primate context, the research seeks to uncover new insights into its causes and how it might be treated.

Dr. Igor Brodsky's lab at the University of Pennsylvania focuses on how the immune system responds to infections by bacteria like Yersinia. His team studies the formation of granulomas, which are organized clusters of immune cells that help contain infections. By understanding the role of specific immune cells like inflammatory monocytes and signaling molecules such as IL-1, the lab aims to uncover mechanisms that control bacterial infections and influence public health.

Dr. David Piston's lab at Washington University focuses on understanding and developing treatments for diabetes and autoimmune diseases. They are particularly interested in how proteins from brown fat can regulate insulin levels and glucagon secretion to improve diabetes management. Additionally, they study the role of specific ion channels in the immune response, which could lead to new therapies for chronic inflammation and cancer.

Dr. Paul S. Buckmaster's lab focuses on understanding the mechanisms that lead to seizures in patients with temporal lobe epilepsy. By studying certain brain cells known as reelin-positive interneurons in both animal models and human cases, the lab aims to identify their role in seizure development. The ultimate goal is to uncover causes of epilepsy that can improve treatment options for affected individuals.

Dr. Julian G. Hurdle's lab focuses on understanding the increasing resistance of Clostridium difficile to antibiotics, particularly vancomycin. Their research aims to uncover the genetic changes in these bacteria that lead to treatment failures in patients. The lab uses clinical studies and genetic analyses to improve treatment strategies and ultimately contribute to better health outcomes for patients suffering from C. difficile infections.

Dr. Ling Cai's lab focuses on understanding how prostate cancer evades the immune system, particularly through epigenetic regulation. They investigate a specific epigenetic factor, TNRC18, that plays a crucial role in silencing immune-related genes, which contributes to the disease's immune resistance. By targeting this factor, the lab aims to develop new strategies to make prostate cancer more responsive to immunotherapies.

Dr. James S. Malter's lab focuses on understanding how calcium signaling affects neuron health in Alzheimer's disease. The team is studying the entorhinal cortex and hippocampus to identify mechanisms that contribute to memory deficits. By investigating specific proteins involved in calcium regulation, they aim to find potential treatments to improve cognitive function in early stages of Alzheimer's disease.

Dr. Gyorgy Hajnoczky's lab focuses on understanding how changes in calcium levels within mitochondria affect neuronal health. They explore the role of specific proteins, particularly the MICU family, in calcium signaling and how their dysfunction can lead to neurological disorders. By using advanced imaging techniques and mouse models, the lab aims to determine the connections between mitochondrial calcium homeostasis, neurodegeneration, and brain functioning in different conditions, such as hypoxia and developmental stages.

Dr. Silvia N. Moreno's research lab focuses on understanding how the Toxoplasma gondii parasite uses calcium signaling for infection and survival. They aim to identify new drug targets to combat reactivation of this common parasite that poses severe risks to immunocompromised individuals and pregnant women. By uncovering the mechanisms of calcium channels and other critical pathways, the lab is working towards developing more effective treatments for toxoplasmosis.

Dr. John Nelson Campbell's lab at the University of Virginia focuses on understanding the neural circuits that control body weight and heart rate. By using advanced techniques like viral tracing and molecular profiling, the team investigates how specific types of neurons influence appetite and metabolism, as well as heart function. This research aims to identify new targets for treating obesity and heart disease by unraveling the complex connections between these neural pathways and their effects on health.

Dr. April M. Weissmiller's lab focuses on understanding how certain mutations in cancer-related proteins affect tumor development, specifically looking at the interplay between the SWI/SNF complex and the MYC oncoprotein. The lab investigates how these connections influence gene expression in cancer cells lacking a specific protein called BRG1. By examining these relationships, the lab aims to uncover new mechanisms behind cancer progression, potentially leading to better approaches for treatment.